Last reviewed · How we verify
Ascites replacement with hartmann's solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ascites replacement with hartmann's solution (Ascites replacement with hartmann's solution) — Seoul National University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ascites replacement with hartmann's solution TARGET | Ascites replacement with hartmann's solution | Seoul National University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ascites replacement with hartmann's solution CI watch — RSS
- Ascites replacement with hartmann's solution CI watch — Atom
- Ascites replacement with hartmann's solution CI watch — JSON
- Ascites replacement with hartmann's solution alone — RSS
Cite this brief
Drug Landscape (2026). Ascites replacement with hartmann's solution — Competitive Intelligence Brief. https://druglandscape.com/ci/ascites-replacement-with-hartmann-s-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing